These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17892366)

  • 1. Peptidomics analysis of human blood specimens for biomarker discovery.
    Tammen H; Peck A; Budde P; Zucht HD
    Expert Rev Mol Diagn; 2007 Sep; 7(5):605-13. PubMed ID: 17892366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
    deVera IE; Katz JE; Agus DB
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncopeptidomics--a commentary on opportunities and limitations.
    Tammen H; Zucht HD; Budde P
    Cancer Lett; 2007 Apr; 249(1):80-6. PubMed ID: 17275178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
    Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidomics coming of age: a review of contributions from a bioinformatics angle.
    Menschaert G; Vandekerckhove TT; Baggerman G; Schoofs L; Luyten W; Van Criekinge W
    J Proteome Res; 2010 May; 9(5):2051-61. PubMed ID: 20377245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL; Blanco-Colio LM; Tunon J; Gomez-Guerrero C; Michel JB; Meilhac O; Egido J
    Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomics: identification of pathogenic and marker peptides.
    Xiang Y; Kurokawa MS; Kanke M; Takakuwa Y; Kato T
    Methods Mol Biol; 2010; 615():259-71. PubMed ID: 20013215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of a current role of mass spectrometry for proteome research.
    Chen CH
    Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in mass spectrometry-based peptidome analysis.
    Hu L; Ye M; Zou H
    Expert Rev Proteomics; 2009 Aug; 6(4):433-47. PubMed ID: 19681678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors--a proof of concept study.
    Tammen H; Hess R; Rose H; Wienen W; Jost M
    Peptides; 2008 Dec; 29(12):2188-95. PubMed ID: 18804500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein arrays for biomarker discovery.
    Reid JD; Parker CE; Borchers CH
    Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
    Greening DW; Kapp EA; Simpson RJ
    Enzymes; 2017; 42():27-64. PubMed ID: 29054270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of micro- and nano-HPLC to the determination and characterization of bioactive and biomarker peptides.
    Saz JM; Marina ML
    J Sep Sci; 2008 Feb; 31(3):446-58. PubMed ID: 18266259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma-derived microparticles for biomarker discovery.
    Smalley DM; Ley K
    Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
    Rifai N; Gillette MA; Carr SA
    Nat Biotechnol; 2006 Aug; 24(8):971-83. PubMed ID: 16900146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human saliva proteome analysis and disease biomarker discovery.
    Hu S; Loo JA; Wong DT
    Expert Rev Proteomics; 2007 Aug; 4(4):531-8. PubMed ID: 17705710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery by comprehensive phenotyping for autoimmune diseases.
    Kantor AB; Wang W; Lin H; Govindarajan H; Anderle M; Perrone A; Becker C
    Clin Immunol; 2004 May; 111(2):186-95. PubMed ID: 15137951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.